FDA Inspection 1168226 — Kyowa Hakko Bio Co., Ltd.
The FDA completed an inspection of Kyowa Hakko Bio Co., Ltd. on Apr 15, 2022 in Hofu. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 15, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hofu (Japan)